跳至主要内容
临床试验/CTRI/2024/07/071212
CTRI/2024/07/071212尚未招募2 期

Phase II Non-randomized clinical study on Bala Karappan(Atopic Dermatitis) with the evaluation of siddha trial drug Yazhpanathennai(internal)and Nathaisoori ennai(external)in children.

Government Siddha Medical College1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年10月3日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Reduction in EASI score(Eczema Area Severity Index)

研究概览

简要总结

This is a single Non-Randomized open clinical trial to study the safety and efficacy of siddha trial drug Yazhpanathennai (internal) is to be given 4 ml once a day for 10 days and External application of Nathaisoori Ennai on the affected area.Clinical trial conducted after conducting pre clinical study. The trial drug Yazhpanathennai has mentioned in Koshayi anuboga vaidya bramma ragasiyam,part-2 and External application of Nathaisoori Ennai has mentioned in Sarapendra vaithya muraigal. During the trial study related data will be recorded and documented. After the completion of the trial all data will be statistically analysed.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
3.00 Year(s) 至 7.00 Year(s)(—)
性别
All

入选标准

  • •Itching Erythema Papules Vesicles Oozing Crusting Scaling Lichenification.

排除标准

  • •Psoriasis Scabies Photo dermatitis Ichthyosis vulgaris Pityriasis alba.

结局指标

主要结局

Reduction in EASI score(Eczema Area Severity Index)

时间窗: 10 Days

Reduction in clinical symptoms like itching,papules,pustules,

时间窗: 10 Days

Oozing,scaling,lichenification

时间窗: 10 Days

次要结局

  • It is assessed by comparing the safety parameters before and after treatment(10 Days)

研究者

发起方
Government Siddha Medical College
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr D Indrabala

Government Siddha Medical College Arumbakkam Chennai

研究点 (1)

Loading locations...

相似试验